SCNI

Scinai Immunotherapeutics Ltd.

2.22

-0.11-4.72%

After Hours: 2.280 +0.060 +2.70%19:59 06/13 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.320/2.330

TODAY RANGE2.220-2.320

VOL55.28K

MARKET CAP2.22M

52 WEEK RANGE1.900-8.92

AVG VOL (3M)357.14K

% TURNOVER5.53%

TURNOVER--

P/E (TTM)0.3732

% RANGE3.00%

EPS(TTM)5.95

P/E(FORWARD)-1.1100

P/B0.1898

BVPS11.70

DIVIDEND--

P/S11,100.00

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.87M

SHARES OUTSTANDING999.92K

NEXT EARNINGS--

FREE FLOAT844.52K

LOT SIZE1

EX-DATE05/21/2024

News

Press Releases

Financial Reports

Profile

TipRanks·1d ago
Scinai Immunotherapeutics Announces New Funding and CDMO Growth Ahead of BIO 2025
Benzinga·06/06 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·06/06 12:07
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·06/05 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·06/05 17:58
Scinai Immunotherapeutics Secures Italian Approval for Pincell Acquisition
TipRanks·06/05 03:55
Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth
TipRanks·06/03 03:54
Scinai Immunotherapeutics Reports Strong CDMO Growth
TipRanks·06/02 12:27
Scinai Immunotherapeutics Reports Strong Q1 2025 CDMO Revenue Growth
Seeking Alpha·05/30 13:55
Scinai Immunotherapeutics reports Q1 results
Seeking Alpha·05/07 21:46
Scinai Immunotherapeutics reports FY results
Benzinga·05/01 11:41
Scinai to Discuss Monoclonal Antibody PC111 for Rare Skin Diseases in Upcoming Webinar
TipRanks·04/29 22:17
Scinai Immunotherapeutics Delays Annual Report Filing
TipRanks·03/27 16:48
Scinai Immunotherapeutics to Acquire Pincell for Novel Skin Disorder Treatment
Benzinga·03/27 13:27
Scinai Immunotherapeutics Signs An Option Agreement To Acquire Rare Disease Company Pincell And Its Novel Antibody For Treating Severe Dermatological Conditions; No Financial Terms Of Transaction Disclosed; Files An Application For €12 Million Grant To Fund Next Stage Of Development
TipRanks·03/05 22:24
Scinai Immunotherapeutics Secures $10 Million Equity Agreement

Same Industry

Name/Symbol

Change%

Price

Scinai Immunotherapeutics Ltd.

SCNI

-4.72%

2.22

Regeneron Pharmaceuticals

REGN

+1.42%

529.24

Entero Therapeutics

ENTO

-11.02%

0.4903

BIONTECH

BNTX

+1.57%

106.57

United Therapeutics Corp.

UTHR

-0.98%

283.35

Vertex Pharmaceuticals Inc

VRTX

-1.00%

455.45

Siga Technologie

SIGA

-1.24%

6.36

Moderna

MRNA

-2.49%

26.67

Charles Riv Labs Intl Inc

CRL

-1.61%

149.45

Medpace Holdings

MEDP

-1.89%

298.25

Talphera Inc

TLPH

-3.64%

0.4900

ICON PLC

ICLR

-0.97%

145.66

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

-1.41%

156.89

MOLECULAR PARTNERS AG

MOLN

-1.54%

3.84

PRA Health

PRAH

165.21

Gilead Sciences Inc

GILD

-1.15%

109.98

Arcturus Therape

ARCT

-2.06%

12.38

Incyte Corp

INCY

-2.12%

67.75

Aptevo Therapeutics Inc

APVO

-8.16%

4.39

Biospecifics

BSTC

+0.15%

88.53